United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts $295.35 +4.96 (+1.71%) As of 02:28 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics Earnings Summary United Therapeutics posted Q1 2025 earnings on April 30, 2025, reporting an EPS of $6.63, which beat the consensus estimate of $6.29 by $0.34. Quarterly revenue rose 17.2% year-over-year to $794.40 million, above analysts' expectations of $726.82 million. With a trailing EPS of $25.06 and a P/E Ratio of 11.79, United Therapeutics' earnings are expected to grow 12.30% next year, from $24.48 to $27.49 per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (Apr. 30) $6.29 Actual EPS (Apr. 30) $6.63 Beat By $0.34 Actual Revenue (Apr. 30) $794.40MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K) Slide DeckSEC FilingUTHR Upcoming EarningsUnited Therapeutics' Q2 2025 earnings is scheduled for Wednesday, July 30, 2025, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get United Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on United Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUTHR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.UTHR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. United Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253$6.36$7.07$6.64Q2 20253$6.23$8.08$7.11Q3 20253$6.48$8.50$7.34Q4 20253$6.30$6.75$6.56 FY 2025 12 $25.37 $30.40 $27.64 Q1 20261$6.75$6.75$6.75Q2 20261$6.05$6.05$6.05Q3 20261$6.19$6.19$6.19Q4 20261$5.87$5.87$5.87 FY 2026 4 $24.86 $24.86 $24.86 Q1 20271$5.86$5.86$5.86 United Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)-------4/30/2025Q1 2025$6.29$6.63+$0.34$6.63$726.82M$794.40M2/26/2025Q4 2024$6.10$6.19+$0.09$6.19$734.74M$735.90M10/30/2024Q3 2024$6.16$6.39+$0.23$6.39$722.62M$748.90M7/31/2024Q2 2024$6.33$5.85 -$0.48$5.85$691.87M$714.90M5/1/2024Q1 2024$5.63$6.17+$0.54$6.17$620.31M$677.70M2/21/2024Q4 2023$4.28$4.36+$0.08$4.36$575.01M$614.70M11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82M$609.40M8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18M$596.50M United Therapeutics Earnings - Frequently Asked Questions When is United Therapeutics' earnings date? United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on UTHR's earnings history. Did United Therapeutics beat their earnings estimates last quarter? In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $6.63 earnings per share (EPS) to beat the analysts' consensus estimate of $6.29 by $0.34. Learn more on analysts' earnings estimate vs. UTHR's actual earnings. How can I listen to United Therapeutics' earnings conference call? The conference call for United Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read United Therapeutics' conference call transcript? The conference call transcript for United Therapeutics' latest earnings report can be read online. Read Transcript How can I view United Therapeutics' earnings report? United Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $2.88 billion. How much profit does United Therapeutics generate each year? United Therapeutics (NASDAQ:UTHR) has a recorded net income of $1.20 billion. UTHR has generated $25.06 earnings per share over the last four quarters. What is United Therapeutics' price-to-earnings ratio? United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 11.59 and a forward price-to-earnings ratio of 11.86. The price/earnings-to-growth ratio is 6.45. What is United Therapeutics' EPS forecast for next year? United Therapeutics' earnings are expected to grow from $24.48 per share to $27.49 per share in the next year, which is a 12.30% increase. More Earnings Resources from MarketBeat Related Companies ALNY Earnings Results BIIB Earnings Results INCY Earnings Results NBIX Earnings Results EXEL Earnings Results BMRN Earnings Results EXAS Earnings Results RGEN Earnings Results MDGL Earnings Results HALO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:UTHR) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Cold War “Accident” Could Unleash New $100 Trillion AI BoomObscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
